Viridian Therapeutics Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2032, Common Stock and Series B Non-Voting Convertible Preferred Stock
businesswire.com
⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in